Press Release
Article Category
Tofacitinib the first FDA approved JAK inhibitor
An overview of Tofacitinib, the first FDA approved JAK inhibitor, and its Indications Introduction Tofacitinib
JAK inhibitors As a New Therapeutic Option
Introduction The JAK/STAT signaling pathway is an universally expressed intracellular signal transduction pathway; involved
Therapy for Hepatocellular Carcinoma
Advances of Targeted Therapy for Hepatocellular Carcinoma Hepatocellular carcinoma (HCC) is categorized as one
Graft-versus-Host Disease (GvHD)
Quick Review over Graft-versus-Host Disease (GvHD) Introduction: Graft-versus-Host Disease (GvHD) is a common complication
Waldenstrom Macroglobulinemia (WM)
Introduction of Waldenstrom Macroglobulinemia (WM) Waldenstrom Macroglobulinemia (WM) is a non-Hodgkin lymphoma (NHL),
Marginal Zone Lymphoma (MZL)
Quick overview of Marginal Zone Lymphoma (MZL): Marginal zone lymphoma (MZL) which is also
Mantle cell lymphoma (MCL)
Quick overview of Mantle cell lymphoma (MCL) Mantle cell lymphoma (MCL) is grouped
Small Lymphocytic Lymphoma SLL
Small Lymphocytic Lymphoma (SLL) overview: Chronic lymphocytic leukemia (CLL) and Small Lymphocytic Lymphoma
Chronic lymphocytic leukemia (CLL)
Quick review over chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia which is also called CLL